BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27993894)

  • 1. Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma.
    Tian H; Ge C; Zhao F; Zhu M; Zhang L; Huo Q; Li H; Chen T; Xie H; Cui Y; Yao M; Li J
    Carcinogenesis; 2017 Feb; 38(2):207-217. PubMed ID: 27993894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.
    Xu MY; Chen R; Yu JX; Liu T; Qu Y; Lu LG
    Cancer Lett; 2016 May; 374(2):241-9. PubMed ID: 26902423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
    Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Guo B; Peng BG
    BMC Cancer; 2018 Aug; 18(1):815. PubMed ID: 30103712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.
    Jiang Z; Zhou Q; Ge C; Yang J; Li H; Chen T; Xie H; Cui Y; Shao M; Li J; Tian H
    Cancer Lett; 2019 Apr; 447():1-11. PubMed ID: 30673593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the zinc-α2-glycoprotein accelerates apoptosis and inhibits growth via the mTOR/PTEN signaling pathway in gastric carcinoma cells.
    Li W; Liu J
    Life Sci; 2020 Jan; 240():117117. PubMed ID: 31790689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
    Tang B; Qi G; Tang F; Yuan S; Wang Z; Liang X; Li B; Yu S; Liu J; Huang Q; Wei Y; Zhai R; Lei B; Yu H; Jiao X; He S
    Oncotarget; 2015 May; 6(14):12723-39. PubMed ID: 25909289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition.
    Ye M; Fang Z; Gu H; Song R; Ye J; Li H; Wu Z; Zhou S; Li P; Cai X; Ding X; Yu S
    Tumour Biol; 2017 Jun; 39(6):1010428317705034. PubMed ID: 28653891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemerin suppresses hepatocellular carcinoma metastasis through CMKLR1-PTEN-Akt axis.
    Li JJ; Yin HK; Guan DX; Zhao JS; Feng YX; Deng YZ; Wang X; Li N; Wang XF; Cheng SQ; Bao Y; Xie D
    Br J Cancer; 2018 May; 118(10):1337-1348. PubMed ID: 29717200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.
    Dai H; Li M; Yang W; Sun X; Wang P; Wang X; Su J; Wang X; Hu X; Zhao M
    Aging (Albany NY); 2020 Jun; 12(12):11717-11731. PubMed ID: 32530437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
    Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
    Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL1 overexpression is correlated with poor prognosis and promotes hepatocellular carcinoma via PTEN.
    Tian QH; Zhang MF; Zeng JS; Luo RG; Wen Y; Chen J; Gan LG; Xiong JP
    J Mol Med (Berl); 2019 Nov; 97(11):1535-1545. PubMed ID: 31463732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.